Study of KN026 Combined With KN046 in Patients With Locally Advanced HER2-positive Solid Tumors

NCT04521179 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

102

Enrollment

INDUSTRY

Sponsor class

Conditions

HER2-positive Solid Tumors

Interventions

DRUG: KN026 combination

Sponsor

Jiangsu Alphamab Biopharmaceuticals Co., Ltd

Collaborators

[object Object]